- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Dr. Salomé Cisnal de Ugarte
News 51 results
Cases & Deals
April 15, 2025
King & Spalding Represents Atlas in Its Approximately £263 Million Acquisition of De La Rue
In the News · Source: Law360 and The Lawyer
April 15, 2025
K&S advises Atlas Holdings on its £263M acquisition of currency printer De La Rue
In the News · Source: Global Legal Chronicle
Events 15 results
Speaking Engagement
March 20, 2025
Salome Cisnal de Ugarte to Speak at Brussels’ Competition Law Conference
Speaking Engagement
January 29, 2025
Dr. Salomé Cisnal de Ugarte and Olivier Antoine to Speak at GCR’s Law Leaders Global Conference in Miami
Speaking Engagement
January 21, 2025
Dr. Salomé Cisnal de Ugarte to Speak at "GCR Live: Law Leaders Global 2025” Miami Conference
Speaking Engagement
October 17, 2024
Dr. Salomé Cisnal de Ugarte to Speak at the XV National Competition Conference
Insights 14 results
Article · Source: Journal of European Competition Law & Practice
April 3, 2025
Geo-blocking, copyright, and the boundaries of EU competition law: Case T-172/21 Valve v Commission
Client Alert
February 28, 2025
Europe’s new Clean Industrial Deal to accelerate decarbonization, reindustrialization and innovation
Thought Leadership
September 6, 2024
Salomé Cisnal de Ugarte Appointed as Non-Governmental Advisor (NGA) to the European Commission at the International Competition Network (ICN)
Article · Source: The Guide to Life Sciences - Third Edition
August 14, 2024
European Union: Commission zeroes in on innovation in merger control and pay-for-delay cases